Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 68788-9809

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 68788-9809). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

3a53f18e Af9b 4932 8300 B3521e87528d 01

FDA Label Image

3a53f18e Af9b 4932 8300 B3521e87528d 02

FDA Label Image

3a53f18e Af9b 4932 8300 B3521e87528d 03

This is a product description for Lisinopril & HCTZ, a generic medication that contains Lisinopril 10mg and Hydrochlorothiazide 12.5mg, and is equivalent to Zestoretic. It is manufactured by Lupin Pharmaceuticals in Maryland, US. The package contains 10mg/12.5mg tablets with a specified expiry date, lot and batch number. The product label includes dosage and usage instructions, as well as a reminder that Federal law prohibits the transfer of the medication to anyone other than the patient for whom it was prescribed. There is also some unclear text that cannot be evaluated for content.*

FDA Label Image

3a53f18e Af9b 4932 8300 B3521e87528d 04

FDA Label Image

3a53f18e Af9b 4932 8300 B3521e87528d 05

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.